109113-72-6 2-(Chloromethyl)-4-methylquinazoline 99%

Tikvah Pharma, we are committed to delivering comprehensive, end-to-end solutions for the API (Active Pharmaceutical Ingredient) industry. We specialize in the development of APIs, API intermediates, New Chemical Entities (NCE), and Regulatory Starting Materials (RSM), covering every stage of the pharmaceutical value chain with precision and innovation. Our expertise ensures high-quality, efficient, and scalable solutions that drive excellence in drug development and manufacturing. With a strong focus on quality and regulatory compliance, we empower our partners to accelerate product development and achieve seamless global market success. As a Contract Research, Development, and Manufacturing Organization (CRO-CDMO), we extend our support to meet the evolving needs of the pharmaceutical industry.